277 related articles for article (PubMed ID: 16596217)
1. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
[TBL] [Abstract][Full Text] [Related]
2. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
[TBL] [Abstract][Full Text] [Related]
3. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.
Yamashita K; Upadhay S; Mimori K; Inoue H; Mori M
Cancer; 2003 May; 97(10):2412-9. PubMed ID: 12733139
[TBL] [Abstract][Full Text] [Related]
5. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.
Rodríguez-Jiménez FJ; Caldés T; Iniesta P; Vidart JA; Garcia-Asenjo JL; Benito M
Oncol Rep; 2007 Jun; 17(6):1301-7. PubMed ID: 17487382
[TBL] [Abstract][Full Text] [Related]
7. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the gene expression of SPARC and its prognostic value for bladder cancer.
Yamanaka M; Kanda K; Li NC; Fukumori T; Oka N; Kanayama HO; Kagawa S
J Urol; 2001 Dec; 166(6):2495-9. PubMed ID: 11696817
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.
Watkins G; Douglas-Jones A; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):267-72. PubMed ID: 15763438
[TBL] [Abstract][Full Text] [Related]
10. Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Drebber U; Hoelscher AH; Schneider PM
World J Gastroenterol; 2006 Jan; 12(3):437-42. PubMed ID: 16489645
[TBL] [Abstract][Full Text] [Related]
11. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
[TBL] [Abstract][Full Text] [Related]
12. Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells.
Watkins G; Martin TA; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):273-8. PubMed ID: 15763439
[TBL] [Abstract][Full Text] [Related]
13. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage.
Friess H; Guo XZ; Tempia-Caliera AA; Fukuda A; Martignoni ME; Zimmermann A; Korc M; Büchler MW
J Clin Oncol; 2001 May; 19(9):2422-32. PubMed ID: 11331321
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.
Wang L; Friess H; Zhu Z; Graber H; Zimmermann A; Korc M; Reubi JC; Büchler MW
Clin Cancer Res; 2000 Feb; 6(2):566-71. PubMed ID: 10690540
[TBL] [Abstract][Full Text] [Related]
16. Gene Expression of Col11A1 Is a Marker Not only for Pancreas Carcinoma But also for Adenocarcinoma of the Papilla of Vater, Discriminating Between Carcinoma and Chronic Pancreatitis.
Kleinert R; Prenzel K; Stoecklein N; Alakus H; Bollschweiler E; Hölscher A; Warnecke-Eberz U
Anticancer Res; 2015 Nov; 35(11):6153-8. PubMed ID: 26504042
[TBL] [Abstract][Full Text] [Related]
17. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas.
Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H
Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313
[TBL] [Abstract][Full Text] [Related]
18. Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancer.
Bloomston M; Ellison EC; Muscarella P; Al-Saif O; Martin EW; Melvin WS; Frankel WL
Ann Surg Oncol; 2007 Jan; 14(1):211-7. PubMed ID: 17080236
[TBL] [Abstract][Full Text] [Related]
19. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
20. [Carcinoma of the pancreas head, papilla Vateri, and cystadenocarcinoma--different biologic entities and different results].
Gebhardt C; Köhler J; Jurowich C
Zentralbl Chir; 2003 May; 128(5):396-400. PubMed ID: 12813638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]